Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Government Support, China Medical City Looks To Separate Itself From The Pack

This article was originally published in PharmAsia News

Executive Summary

NEW YORK - Perhaps the largest hurdle China Medical City faces with a U.S. audience is explaining how it differs from China's more established science and technology parks like Zhangjiang Hi Tech Park in Shanghai, Zhong-guan-cun Life Science Park in Beijing and BioBay in Suzhou
Advertisement

Related Content

AstraZeneca Invests $200 Million For Manufacturing Plant In China Medical City
Asia Spotlight: Meet China’s New Innovators – Hua Medicine Looks To Take Flight With U.S. Venture Backing
Meet China’s New Innovators: Hua Medicine Looks To Take Flight With U.S. Venture Backing (Part 1)
From Biosimilars To Corporate Venture: China's Top Biotech Takes Another Step
From Biosimilars To Corporate Venture: China's Top Biotech Takes Another Step
Takeda Unveils R&D, Commercial Realignments To Try For Post-Patent Gains
Takeda Unveils R&D, Commercial Realignments To Try For Post-Patent Gains
Chinese Pharma Simcere Files IND For Humanized Rabbit Monoclonal Antibody
BIO Welcomes First Chinese Members: Shanghai Zhangjiang Park And Taizhou Medical City
Yangtze Delta Expected To Be Largest CRO Cluster By 2015
Advertisement
UsernamePublicRestriction

Register

SC078877

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel